Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Dugo, Matteo"'
Autor:
Licata L; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy.; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy., Barreca M; University of Milano-Bicocca, Milan, Italy., Galbardi B; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy.; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy., Dugo M; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy.; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy., Viale G; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy.; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy., Győrffy B; Department of Bioinformatics, Semmelweis University, Budapest, Hungary.; Cancer Biomarker Research Group, Research Centre for Natural Sciences, Budapest, Hungary., Karn T; Goethe University Hospital Frankfurt, Frankfurt, Germany., Pusztai L; Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA., Gianni L; Michelangelo Foundation, Milan, Italy., Callari M; Michelangelo Foundation, Milan, Italy. maurizio.callari@fondazionemichelangelo.org., Bianchini G; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy. bianchini.giampaolo@hsr.it.; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy. bianchini.giampaolo@hsr.it.
Publikováno v:
British journal of cancer [Br J Cancer] 2023 Dec; Vol. 129 (12), pp. 2025-2033. Date of Electronic Publication: 2023 Nov 07.
Autor:
Magni M; Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Department of Oncology and Hemato-oncology, Università degli Studi di Milano, Milan, Italy., Biancon G; Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Department of Oncology and Hemato-oncology, Università degli Studi di Milano, Milan, Italy.; Yale University School of Medicine, Comprehensive Cancer Center, Hematology, New Haven, CT, 06511, USA., Rizzitano S; Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Department of Oncology and Hemato-oncology, Università degli Studi di Milano, Milan, Italy., Cavanè A; Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Paolizzi C; Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Dugo M; Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Corradini P; Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Department of Oncology and Hemato-oncology, Università degli Studi di Milano, Milan, Italy., Carniti C; Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. cristiana.carniti@istitutotumori.mi.it.
Publikováno v:
British journal of cancer [Br J Cancer] 2019 Oct; Vol. 121 (7), pp. 567-577. Date of Electronic Publication: 2019 Sep 02.